KP

Karl Pfleger

North America, California, United States, San Francisco

Description

Karl Pfleger

Investor Profile

Karl Pfleger has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Seed (50%)

Country Focus

  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Karl Pfleger frequently co-invest with?

Plum Alley
North America, New York, United States, New York
Co-Investments: 1
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Manta Ray Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Compound
North America, New York, United States, New York
Co-Investments: 1
Felicis
North America, California, United States, Menlo Park
Co-Investments: 1
Intersect VC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Horizons Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
BoxOne Ventures
North America, Quebec, Canada, Montréal
Co-Investments: 1
Irongrey
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

Which angels does Karl Pfleger often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 1
TE
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Karl Pfleger?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000
Juvena Therapeutics

Palo Alto, California, United States

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

BiopharmaBiotechnologyHealth Care
Series ANov 8, 2022
Amount Raised: $41,000,000